Glucagon-like peptide-1 levels on admission for acute myocardial infarction with or without acute hyperglycemia

Int J Cardiol. 2014 Oct 20;176(3):1214-6. doi: 10.1016/j.ijcard.2014.07.221. Epub 2014 Aug 5.

Affiliations

¹ Division of Cardiology, Yokohama City University Medical Center, Yokohama, Japan. Electronic address: [email protected].
² Division of Cardiology, Yokohama City University Medical Center, Yokohama, Japan.
³ Division of Cardiovascular Diseases, Mayo College of Medicine, Rochester, MN, United States.
⁴ Department of Medical Science and Cardiorenal Medicine, Yokohama City University Graduate School of Medicine, Yokohama, Japan.

PMID: 25125017
DOI: 10.1016/j.ijcard.2014.07.221

No abstract available

Keywords: Acute myocardial infarction; Diabetes; Hyperglycemia; Incretin.

Publication types

Research Support, Non-U.S. Gov't

MeSH terms

Acute Disease
Biomarkers / blood
Electrocardiography
Female
Glucagon-Like Peptide 1 / blood*
Humans
Hyperglycemia / blood
Hyperglycemia / complications*
Male
Middle Aged
Myocardial Infarction / blood*
Myocardial Infarction / complications
Myocardial Infarction / therapy
Patient Admission*
Prognosis

Substances

Biomarkers
Glucagon-Like Peptide 1